U.K. Pharmaceuticals & Biotech High Growth Potential Companies

Oxford Biomedica

Market Cap: UK£295.7m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Diaceutics

Market Cap: UK£95.1m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

Futura Medical

Market Cap: UK£30.1m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Shield Therapeutics

Market Cap: UK£21.1m

A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.

AstraZeneca

Market Cap: UK£155.2b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Alliance Pharma

Market Cap: UK£347.6m

A holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.

ECO Animal Health Group

Market Cap: UK£35.6m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Indivior

Market Cap: UK£857.1m

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Tissue Regenix Group

Market Cap: UK£26.7m

A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.

LungLife AI

Market Cap: UK£275.9k

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

Genus

Market Cap: UK£1.1b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

GSK

Market Cap: UK£52.5b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

HUTCHMED (China)

Market Cap: UK£1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.